Research Article
Cytomegalovirus Antibody Elevation in Bipolar Disorder:
Relation to Elevated Mood States
A. R. Prossin,
1,2
R. H. Yolken,
3
M. Kamali,
4
M. M. Heitzeg,
4
J. B. Kaplow,
1
W. H. Coryell,
5
and M. G. McInnis
4
1
Department of Psychiatry, University of Texas Health Science Center at Houston, 1941 East Road, No. 2308, Houston, TX 77054, USA
2
Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
3
Stanley Laboratory of Developmental Neurovirology, Johns Hopkins University Medical Center, Baltimore, MD 21287, USA
4
Department of Psychiatry, University of Michigan Medical School, Ann Arbor, MI 48109, USA
5
Department of Psychiatry, University of Iowa School of Medicine, Iowa City, IA 52242, USA
Correspondence should be addressed to A. R. Prossin; alan.prossin@uth.tmc.edu
Received 11 September 2014; Accepted 23 October 2014
Academic Editor: Jo˜ ao Quevedo
Copyright © A. R. Prossin et al. his is an open access article distributed under the Creative Commons Attribution License, which
permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
he neurobiology of mood states is complicated by exposure to everyday stressors (e.g., psychosocial, ubiquitous environmental
infections like CMV), each luctuating between latency and reactivation. CMV reactivation induces proinlammatory cytokines
(e.g., TNF-) associated with induction of neurotoxic metabolites and the presence of mood states in bipolar disorder (BD).
Whether CMV reactivation is associated with bipolar diagnoses (trait) or speciic mood states is unclear. We investigated 139BD
type I and 99 healthy controls to determine if concentrations of IgG antibodies to Herpesviridae (e.g., CMV, HSV-1, and HSV-
2) were associated with BD-I diagnosis and speciic mood states. We found higher CMV antibody concentration in BD-I than in
healthy controls (T
234
= 3.1,
uncorr
= 0.002;
corr
= 0.006) but no diference in HSV-1 ( > 0.10) or HSV-2 ( > 0.10). Compared to
euthymic BD-I volunteers, CMV IgG was higher in BD-I volunteers with elevated moods ( < 0.03) but not diferent in depressed
moods ( > 0.10). While relationships presented between BD-I diagnosis, mood states, and CMV antibodies are encouraging,
they are limited by the study’s cross sectional nature. Nevertheless, further testing is warranted to replicate indings and determine
whether reactivation of CMV infection exacerbates elevated mood states in BD-I.
1. Introduction
Bipolar disorder (BD) a mood disorder characterized by
the presence of elevated, irritable, or mixed mood episodes
frequently interspersed with episodes of depression afects
approximately 2-3% of the population [1–3]. Despite sub-
stantial individual and societal impact, knowledge of the
biological processes underlying and driving mood states
in BD is limited. Revealing associations between biological
factors and both mood traits and states will set a trajectory
for understanding the pathophysiology of moods and in
developing novel, more eicacious intervention strategies in
BD.
Ubiquitous environmental infections (e.g., Herpesviridae
including cytomegalovirus; CMV) and associated human
immune responses luctuate between latency and reactivation
in humans, potentially triggered by psychosocial stressors [4–
6]. Viruses may facilitate exacerbation of psychiatric disease
pathology through various mechanisms, including induction
of inlammatory factors (e.g., TNF-, IL-6, etc.) [7] or via
direct interactions with speciic illness susceptibility genes. A
recent preliminary fMRI study of pediatric bipolar disorder
may suggest a mechanism whereby alterations in TNF-
related processes could impact some of the symptoms in
BD-I. In this study, Barzman et al. identiied correlations
between 11 TNF- related gene expressions and activation
within the amygdala or anterior cingulate cortex during the
afective Posner task [8]. Evidence from recent studies in BD
also shows that TNF- is higher in BD volunteers compared
to healthy control volunteers [9, 10]. Further, as outlined in
Hindawi Publishing Corporation
Neural Plasticity
Article ID 939780